AI assistant
Sending…
EDGEWELL PERSONAL CARE Co — Director's Dealing 2021
Nov 17, 2021
32283_dirs_2021-11-17_99eaf7e1-9233-4442-8a95-7ab04d77e08f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EDGEWELL PERSONAL CARE Co (EPC)
CIK: 0001096752
Period of Report: 2021-11-15
Reporting Person: IASENZA MARISA (Chief Legal Ofcr & Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-15 | Common Stock | M | 2262 | $0.00 | Acquired | 35864 | Direct |
| 2021-11-15 | Common Stock | F | 1049 | $42.94 | Disposed | 34815 | Direct |
| 2021-11-15 | Common Stock | M | 1909 | $0.00 | Acquired | 36724 | Direct |
| 2021-11-15 | Common Stock | F | 885 | $42.94 | Disposed | 35839 | Direct |
| 2021-11-15 | Common Stock | M | 1171 | $0.00 | Acquired | 37010 | Direct |
| 2021-11-15 | Common Stock | F | 543 | $42.94 | Disposed | 36467 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-15 | Restricted Stock Equivalent 11/13/2020 | $0.00 | M | 2262 | Disposed | Common Stock (2262) | Direct | |
| 2021-11-15 | Restricted Stock Equivalent 11/14/2019 | $0.00 | M | 1909 | Disposed | Common Stock (1909) | Direct | |
| 2021-11-15 | Restricted Stock Equivalent 11/15/2018 | $0.00 | M | 1171 | Disposed | Common Stock (1171) | Direct |
Footnotes
F1: Shares withheld as payment of a tax liability on vesting of restricted stock equivalents.
F2: Restricted stock equivalents vested and converted into shares of EPC common stock on 11/15/2021.
More from EDGEWELL PERSONAL CARE Co
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 19
Major Shareholding Notification
2026
Feb 12
Director's Dealing
2026
Feb 9
Director's Dealing
2026
Feb 9
Director's Dealing
2026
Feb 9